Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptima Health Regulatory News (OPT)

Share Price Information for Optima Health (OPT)

Share Price is delayed by 15 minutes
Get Live Data
187.00    0.00 (0.00%)
Bid:
185.00
Ask:
189.00
Spread: 4.00 (2.162%)
Market Cap: £203.41m
OPT Live PriceLast checked at - London Stock Exchange

Intraday Optima Health Share Chart

Holding(s) in Company

5 May 2026 08:58

RNS Number : 0446D
Optima Health PLC
05 May 2026
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BRSCY602

Issuer Name

OPTIMA HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Harwood Capital LLP

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

Name

City of registered office

Country of registered office

Harwood Capital Management (Gibraltar) Limited

Gibraltar

Gibraltar

Harwood Capital LLP

London

United Kingdom

4. Details of the shareholder

Name

City of registered office

Country of registered office

Harwood Capital LLP

London

United Kingdom

Oryx International Growth Fund Limited

Guernsey

Guernsey

5. Date on which the threshold was crossed or reached

30-Apr-2026

6. Date on which Issuer notified

01-May-2026

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.353900

0.000000

6.353900

6911498

Position of previous notification (if applicable)

5.023900

0.000000

5.023900

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BRSCY602

149001

0.137000

GB00BRSCY602

6762497

6.216900

Sub Total 8.A

6911498

6.353900%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Christopher Harwood Bernard Mills

Harwood Capital LLP

0.137000

0.137000%

Christopher Harwood Bernard Mills

Oryx International Growth Fund Limited

6.216900

6.216900%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

01/05/26

13. Place Of Completion

London Stock Exchange

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUPUMAAUPQUMA
Date   Source Headline
10th Jun 202611:46 amRNSHolding(s) in Company
9th Jun 20269:27 amRNSHolding(s) in Company
29th May 20268:34 amRNSHolding(s) in Company
27th May 202612:40 pmRNSHolding(s) in Company
18th May 202610:51 amRNSHolding(s) in Company
13th May 202612:12 pmRNSHolding(s) in Company
12th May 20265:32 pmRNSHolding(s) in Company
12th May 20261:00 pmRNSHolding(s) in Company
5th May 202610:22 amRNSHolding(s) in Company
5th May 20268:58 amRNSHolding(s) in Company
30th Apr 20263:36 pmRNSHolding(s) in Company
29th Apr 20266:02 pmRNSHolding(s) in Company
28th Apr 202610:39 amRNSHolding(s) in Company
28th Apr 20267:00 amRNSDirector/PDMR Shareholding
27th Apr 20264:27 pmRNSHolding(s) in Company
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 20263:57 pmRNSResult of GM and Underwritten Open Offer
17th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSLaunch of Underwritten Open Offer
30th Mar 20263:20 pmRNSHolding(s) in Company
24th Mar 20264:37 pmRNSIrish FDI Clearance & Expected Acquisition of PAM
23rd Mar 20267:00 amRNSDirectorate Change
12th Mar 20264:04 pmRNSHolding(s) in Company- Replacement
12th Mar 20267:00 amRNSContract Win
12th Mar 20267:00 amRNSContract Win
5th Mar 20263:50 pmRNSHolding(s) in Company
4th Mar 20263:33 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
16th Feb 20267:00 amRNSAppointment of Joint Broker
16th Feb 20267:00 amRNSAcquisition of PAM Healthcare Limited
9th Feb 20269:04 amRNSHolding(s) in Company
2nd Feb 20264:26 pmRNSHolding(s) in Company
10th Dec 20257:00 amRNSInterim Results
13th Nov 20257:00 amRNSNotice of Half Year Results
6th Nov 20252:17 pmRNSHolding(s) in Company
3rd Nov 20255:14 pmRNSHolding(s) in Company
3rd Nov 202511:15 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSHalf Year Trading Update
31st Oct 20252:00 pmRNSHolding(s) in Company
31st Oct 202511:06 amRNSHolding(s) in Company
20th Oct 20254:35 pmRNSHolding(s) in Company
29th Sep 20252:06 pmRNSHolding(s) in Company
23rd Sep 20257:00 amRNS-ROptima Health launches Optima Health Ireland
1st Sep 20254:06 pmRNSResult of AGM
4th Aug 202510:31 amRNSHolding(s) in Company
1st Aug 20252:55 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
14th Jul 20253:21 pmRNSHolding(s) in Company
9th Jul 20256:02 pmRNSHolding(s) in Company
8th Jul 20257:00 amRNSFull Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.